Woojung Bio Inc. (215380) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Woojung Bio Inc. (215380:KRX), powered by AI.

Current Price
₩2,470
P/E Ratio
-7.5
Market Cap
41.6B
Sector
Healthcare
What is the Woojung Bio Inc. stock price forecast?

Woojung Bio Inc. is currently trading at ₩2,470. View real-time AI analysis on Alpha Lenz.

What is Woojung Bio Inc. insider trading activity?

View the latest insider trading data for Woojung Bio Inc. on Alpha Lenz.

What is Woojung Bio Inc.'s P/E ratio?

Woojung Bio Inc.'s P/E ratio is -7.5.

Woojung Bio Inc.

KRX · 215380
₩2,470-30(-1.20%)Market closedKRX regular session 09:00–15:30 KST
Ask about Woojung Bio Inc.'s future dividend policy...
Alpha Chat Insight

Woojung Bio Inc. trades at a P/E of -7.5 (undervalued) with modest ROE of -21.0%.

Ask for details

Company Overview

Woojung Bio Inc. is an esteemed entity within the biotechnology sector, known for its contributions to the development and innovation of healthcare solutions. Primarily, the company engages in the research, production, and distribution of various biopharmaceutical products focused on improving public health outcomes. With a robust portfolio that may include therapeutic drugs, diagnostic kits, and medical devices, Woojung Bio Inc. influences several aspects of the healthcare industry, aiding in the treatment and prevention of diseases. Its operations significantly impact related sectors, such as pharmaceuticals and clinical diagnostics, reinforcing its role as a vital player in the biotechnology market. By leveraging scientific research and cutting-edge technology, Woojung Bio Inc. aims to provide advanced medical solutions, thereby enhancing the quality of life and promoting well-being across global communities.

CEO천희정
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩41,569,052,720Market Cap
₩37,587,048,390Revenue
16.83MShares Out
0Employees

Margins

26.88%Gross
2.47%EBITDA
-9.72%Operating
-14.76%Pre-Tax
-14.76%Net

Valuation

-7.49P/E
1.78P/B
1.11EV/Sales
95.09EV/EBITDA
-46.72P/FCF

Growth (CAGR)

-7.12%Rev 3Yr
0.13%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-6.11%ROA
-21.03%ROE
-2.92%ROIC

Financial Health

₩3,833,700,600Cash & Cash Equivalents
₩59,583,456,550Net Debt
271.27%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Woojung Bio Inc. (ticker: 215380) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $41.6B.

The current price is ₩2,470 with a P/E ratio of -7.49x and P/B of 1.78x.

ROE is -21.03% and operating margin is -9.72%. Annual revenue is $37.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Woojung Bio Inc. (215380) Stock Forecast 2026 ₩2,470 — Price, Financials & Analyst Targets | Alpha Lenz